Vertebrogenic pain is deep back pain in the middle of the spine that comes from a damaged, inflamed vertebral endplate — the thin layer of bone and cartilage where the vertebra meets the disc. The basivertebral nerve carries it. It comes from bone, not disc or joint. Type 1 or Type 2 Modic changes on MRI are its marker.
For most of the history of spine medicine, chronic back pain that did not come from a nerve, a facet joint or the sacroiliac joint was blamed on the disc by default. Vertebrogenic pain is a more specific answer. It points somewhere most patients have never heard of: the vertebral endplate.
The endplate is the thin layer of bone and cartilage at the top and bottom of each vertebra, where the vertebra meets the disc. It carries load. It is also the route that feeds the disc, which has no blood supply of its own, by slow seepage. And it has a nerve. That nerve runs into the middle of the vertebra and is called the basivertebral nerve.
When an endplate is damaged and inflamed, that nerve carries pain. The pain is felt in the middle of the back. It comes from bone, not from disc or joint.
Most axial back pain (pain that stays in the back) has no clear sign on imaging. That is why so much spine diagnosis depends on numbing blocks. Vertebrogenic pain is different. Inflammation and fat changes in the bone next to a damaged endplate show up on MRI. They are called Modic changes. Type 1 means swelling and inflammation. Type 2 means fat has replaced normal marrow.
According to PubMed, the medical literature describes Type 1 and Type 2 Modic changes as objective markers for vertebrogenic pain. They were the entry rule for the randomized trials of treatment aimed at the basivertebral nerve (Smuck M, et al. Interv Pain Med. 2023;2(2):100256. DOI).
That does not make the MRI the whole diagnosis. Modic changes show up in people without pain too. The same rule applies here as everywhere else on this site: the finding has to match the story. But it does make this one of the few kinds of axial back pain (pain that stays in the back) where imaging adds something specific, instead of describing your age.
It overlaps with discogenic pain in almost every symptom. That is why the MRI sign carries real weight here.
History and examination first, looking for the worse-bending, worse-sitting, middle-of-the-back pattern, with no sign of a pinched nerve root.
MRI, read specifically for endplate change. Here the scan type and the reading matter. Modic changes at L3 to S1 are the finding to look for. A report focused on the disc and canal may mention them in passing or not at all. Our post on what each imaging modality can and cannot tell you covers the general idea.
Excluding the alternatives with blocks. Facet joints get a medial branch block. The sacroiliac joint gets a block inside the joint. A nerve root gets a selective nerve root block. All are done under image guidance, under local numbing, with no sedation. Patients are awake, drive themselves home, and are back to normal activity, including work, within two to four hours. This condition looks a lot like other back pain sources. So ruling those out is a big part of ruling this one in.
The evidence for treating the basivertebral nerve is stronger than for many pain procedure targets. It is worth laying out with its limits attached.
According to PubMed, a randomized trial at 20 US sites enrolled 140 patients. They had low back pain for at least six months and Type 1 or Type 2 Modic changes between L3 and S1. They were randomized 1:1. Half got radiofrequency ablation of the basivertebral nerve. Half kept standard care. At three months, the Oswestry Disability Index changed by −25.3 points on average with ablation, against −4.4 with standard care. That is an adjusted difference of 20.9 points. Pain scores fell 3.46 against 1.02. An independent data management committee stopped enrollment early because ablation was clearly better. It offered the control group the chance to switch (Khalil JG, et al. Spine J. 2019;19(10):1620-1632. DOI).
At twelve months, disability scores were down 25.7 points and pain 3.8 cm from the start, on average. Of patients, 64 percent had at least a 50 percent drop in pain, and 29 percent were pain free. Notably, the share of patients using opioids did not change in either group (Smuck M, et al. Reg Anesth Pain Med. 2021;46(8):683-693. DOI). At 24 months, disability had improved 28.5 points and pain 4.1 cm from the start. Of patients, 72.4 percent reported at least 50 percent less pain, and 31 percent were pain free (Koreckij T, et al. N Am Spine Soc J. 2021;8:100089. DOI). Pooled three-year data from two studies showed disability down 31.2 points on average. There were no serious device or procedure side effects over that time (Smuck M, et al. Interv Pain Med. 2023. DOI).
The randomized trial above compared ablation with standard care, and patients knew which group they were in. There was no sham procedure. That matters more for procedures than for drugs, because the placebo effect of a procedure is large and well documented. Enrollment was stopped early at an interim check. Trials stopped early for benefit tend to overstate the effect. And much of the long-term data comes from following only the treated group, without a comparison group.
And, as with nearly all spine trials, enrollment was selective. These studies required a specific MRI marker, a minimum time with symptoms, and no competing diagnoses. They did not enroll the patients who make up much of a real procedure practice. Those patients have several pain sources at once, serious metabolic disease and complex medicine histories. That is not a criticism of the trials — it is how trials work. But it does mean the reported response rates describe a filtered group. They are a starting point for a talk about your spine, not a prediction about it.
Conservative and metabolic care. The endplate is the route that feeds the disc. Endplate health depends on healthy tiny blood vessels. Blood sugar control, inflammation, weight and smoking all act on that directly — see microvascular dysfunction and chronic pain, medical weight management and lifestyle medicine. Graded activity and load management are still the base of the plan.
Treating the generators that coexist. Most patients with endplate change also have pain from facets, the sacroiliac joint or a nerve root. Treating a confirmed second source often changes a lot. Options include facet injections and radiofrequency ablation, sacroiliac joint injection, and epidural steroid injections.
Neuromodulation for confirmed, lasting back pain — spinal cord stimulation, tried before it is implanted.
Intracept basivertebral nerve ablation. When the Modic finding, the symptoms and the ruling out of other sources all agree, radiofrequency ablation of the basivertebral nerve treats the endplate pain directly. Full details, including what to expect on the day, are on the Intracept treatment page.
Fusion is not the answer to vertebrogenic pain as such. Stopping motion at a segment does not treat an inflamed endplate and its nerve. And it shifts load to the levels next to it. The whole interest in this diagnosis comes from it being a specific source we can target without fusing anything.
That is a statement about this condition, not about this practice. Dr. Gurpreet Singh Padda, MD, MBA, MHP is a licensed physician and surgeon with surgical privileges. Surgery is performed here when it is needed.
Surgery enters the talk when something else is present: a pinched nerve with worsening nerve loss, instability, fracture, infection or tumor. Each of those is a separate diagnosis. Each is judged on its own terms, not folded into an explanation for back pain.
Deep back pain in the middle, worse with sitting and bending, that has outlasted several rounds of treatment is worth a specific workup. Do not keep treating it in a general way. We see patients from across St. Louis, Bridgeton, St. Charles and the Illinois Metro East. Call us or request an evaluation.
They are changes in the bone right next to a damaged endplate. Type 1 is swelling and inflammation. Type 2 is fat replacing normal marrow. The medical literature calls them objective markers for vertebrogenic pain. They were the entry rule for the randomized trials of endplate treatment. They are useful, though like every imaging finding they have to match your symptoms. Read more: Basivertebral nerve ablation and vertebrogenic back pain.
The source is different. Disc pain comes from the disc wall, where a tear exposes nerve endings to inflammatory chemicals. Vertebrogenic pain comes from the bony endplate at the top or bottom of the vertebra. The basivertebral nerve carries it. They look almost the same. That is exactly why the MRI sign and ruling out other sources do the work. Read more: Back pain with a normal-looking MRI.
Better than for many procedure targets, with real warnings. A randomized trial at many sites found a 20.9-point edge in disability score over standard care at three months. It was stopped early because ablation was clearly better. Follow-up at two and three years showed lasting gains with no serious device side effects. But patients knew which group they were in, and there was no sham. It was stopped early, which tends to overstate the effect. And the long-term data come mostly from following only the treated group. Read more: Basivertebral nerve ablation and vertebrogenic back pain.
Because an epidural treats inflammation around a nerve root, and vertebrogenic pain does not come from a nerve root. A treatment that fails is useful information. It makes a nerve root source less likely and moves the other suspects up the list. That is a reason to test another way, not to decide nothing can be done. Read more: Why pain injections stop working.
No. The blocks used to rule out facet, sacroiliac and nerve root sources are done under local numbing with no sedation. You stay awake and can respond, which is what makes the test meaningful. Most patients drive themselves home and are back to normal activity, including work, within two to four hours. Read more: What to expect at your first appointment.
No, and it is worth being exact. Endplate treatment targets the nerve carrying pain from the bone. It does not repair a disc, reverse wear or change alignment. What truly shapes the underlying process is the health of the tissue’s blood supply. That means blood sugar control, inflammation, weight and smoking. We treat those here instead of referring them elsewhere. Read more: Microvascular dysfunction and chronic pain.
Having symptoms for a long time is normal in this diagnosis. It does not rule you out. In the published trials, roughly two thirds to 71 percent of patients had had back pain for five years or more. Those were the patients who improved. What matters more than how long is whether the source has ever actually been found. Read more: What waiting for treatment does to your body.
Prefer not to fill in a form?
Same-day and emergency appointments are available.